VivaMed
VivaMed BioPharma is a clinical-stage pharmaceutical company focused on accelerating drug development for urgent health needs such as pain, addiction, neurodegeneration, and rare diseases. They employ a model that combines artificial intelligence, global partnerships, and extensive clinical and operational experience to bring better treatments to market. Their approach de-risks drug development by utilizing regulatory expertise, AI-assisted modeling, and a balanced portfolio of new and repurposed drug assets, aiming to reduce attrition and scale innovation more efficiently than traditional pharma models. VivaMed has over 30 academic and industry partnerships across 13 countries, and has licensed or developed over 150 drug assets, supported 39 regulatory approvals, and has offices in 5 countries.
VivaMed
VivaMed BioPharma is a clinical-stage pharmaceutical company focused on accelerating drug development for urgent health needs such as pain, addiction, neurodegeneration, and rare diseases. They employ a model that combines artificial intelligence, global partnerships, and extensive clinical and operational experience to bring better treatments to market. Their approach de-risks drug development by utilizing regulatory expertise, AI-assisted modeling, and a balanced portfolio of new and repurposed drug assets, aiming to reduce attrition and scale innovation more efficiently than traditional pharma models. VivaMed has over 30 academic and industry partnerships across 13 countries, and has licensed or developed over 150 drug assets, supported 39 regulatory approvals, and has offices in 5 countries.